Third Party Data > Lusis 2006-04-24 Expression Profiling of Liver Tissue from C57BL6 x DBA F2 Mice
A. Jake Lusis, Ph.D.
Thomas A. Drake, M.D. Data contributed by Leslie Ingram-Drake, April 24, 2006 SummaryExpression profiling of liver tissue from 111 F2 female mice resulting from an F2 intercross between C57BL/6J and DBA/2J inbred mouse strains. Mice were additionally studied for obesity, plasma lipid, and atherosclerosis related traits, and genotyped to allow for QTL analysis of phenotypic and expression traits. Phenotype, genotype and liver expression data are provided here. Mice were fed a chow diet for 12 months followed by 4 months of an atherogenic high-fat, high-cholesterol, cholate containing diet (Diet # 90221; Harlan Teklad, Madison, WI). Parental and F2 mice were killed at 16 months of age. Body weight and length measurements were obtained and blood collected immediately prior to sacrifice. The heart and ascending aortae were removed en bloc and embedded in OCT compound and frozen at -70C for subsequent sectioning for atherosclerotic lesion quantitation. Kidneys and spleens were collected for DNA isolation and fat pads (omental, retroperitoneal, parametrial, and subcutaneous) were removed and weighed. The livers were removed immediately and flash frozen at stored at -80C before expression profiling. Blood was collected by retro-orbital bleeding under isoflurane anesthesia from mice fasted for fourteen hours. Samples were collected prior to placement of the mice on the HF diet (chow diet samples) and at time of sacrifice (high fat, or HF, diet samples). Plasma was separated from cells by centrifugation of blood at 12,000 x g for 3 min. Total cholesterol, HDL cholesterol, triglycerides, and unesterified free fatty acids were performed using established enzymatic assays. Plasma insulin and leptin were measured by immunoassay. Data for all these traits from each mouse are provided. Not all traits were able to be obtained on all mice. (See publications PMID: 11328966 and 12925895 for further details. The 111 mice included here are a subset on which expression studies were obtained). Genotyping was performed by PCR amplification of microsatellite markers spaced at an average of 13 cM. PCR products were run on 5% polyacrylamide gels and detected by autoradiography. Genotypes at each marker are designated as B (homozygous C57BL/6J), D (homozygous DBA/2J), or H (heterozygous). Comprehensive microarray analyses were performed using a curated set representing 23,574 murine genes and ESTs, and 2,186 control sequences. Arrays were manufactured by Agilent Technologies, and used 60mer oligonucleotide probes constructed on the arrays using ink-jet technology. Total RNA was extracted using Triazol reagent. For these F2 intercross samples, control RNA is composed of a pool derived from all F2 and parental samples. RNA quality was validated prior to analysis. Portions were reverse transcribed and labeled with either Cy3 fluorochrome or alternatively with Cy5 fluorochrome. Each labeled cDNA was hybridized along with its alternatively-labeled control cDNA on duplicate arrays, with the labeling of sample and control reversed between the two arrays. Array images were scanned using an Agilent Dual Laser Microarray scanner. Data were processed to obtain background noise, single-channel intensities, and associated measurement error estimates, and intensity values were accordingly normalized and background-corrected. Measurements derived were expressed as mean log10 intensity (MI) and mean log10 ratio (MR) of sample to control values, derived from the duplicate reverse-fluor hybridizations. An error model for the MR value was applied to quantify the significance of expression change between sample and control. (See publication PMID: 12646919, and GEO record GDS923 for further details). Data FilesExpression files, comma-separated values (CSV):
a_substance_id - Rosetta generated unique probe identifier
a_substance_id - Rosetta generated unique probe identifier
|
Copyright © 2002 by Diabetes Genome Anatomy Project. All rights reserved. All documents on this Web site are the property of Diabetes Genome Anatomy Project and are protected by copyright. Any reproduction of any document on this Web site which omits Joslin's name or copyright notice is prohibited. Documents on this Web site may be reproduced for personal use only. They may not be distributed or sold. They may not be published in any other format (e.g., book, article, Web site) without the prior, written permission of Diabetes Genome Anatomy Project.
Please contact the webmaster with questions, comments, or suggestions.